Undeniable Benefits of EMR Solutions Continue to Drive Growth of European EMR Markets

Frost & SullivanImproved efficiency and patient safety, better cost containment and the desire to provide integrated healthcare are some of the major factors driving the growth of the European electronic medical record (EMR) markets. EMR offers healthcare providers the opportunity to better manage patient data, create reports and work in an integrated manner, resulting in reduced costs and superior care delivery.

New analysis from Frost & Sullivan (http://healthcareandlifesciencesIT.frost.com), European Electronic Medical Records Markets, reveals that these markets earned revenues of $349.6 million in 2006 and estimates this to reach $1.15 billion in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the latest analysis of European Electronic Medical Records Markets, then send an e-mail to Radhika Menon Theodore, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it. with your full name, company name, title, telephone number, fax number and e-mail address. Upon receipt of the above information, an overview will be sent to you by e-mail.

"Having accurate patient data plays a vital role in treating patients effectively, but this has always depended on maintaining comprehensive records of patients' encounters with the medical system," remarks Frost & Sullivan Senior Research Analyst Kiran John. "EMR provides healthcare professionals and nursing and administrative staff instant access to the right information from multiple points, and EMR data can be sourced, accessed, edited, appended and maintained effortlessly."

The cost savings potential of EMR in both primary and hospital care is perhaps the most compelling factor driving its uptake, given that cost containment is a top priority for governments and providers alike. The time and costs associated with basic but essential activities such as creating and storing charts and employing adequate nursing and administrative staff for these purposes can be reduced significantly by adopting an EMR system.

However, considering the highly fragmented nature of the European EMR markets owing to Europe's innate diversity and the varying levels of penetration of healthcare information technology (HIT), healthcare authorities are undertaking a standardisation drive in an attempt to provide better care delivery. Vendors with a European presence are particularly affected, as they need to customise or even re-invent their products and price them differently.

This has raised the question of creating unique patient identities, which many believe is critical to create a strong foundation on which EMR can be rolled out. There has been an ongoing debate about this issue and whether certification is really required for EMR solutions, and the answer will have a direct bearing on both technology adoption and solution creation.

"The need for unique patient identities is critical to the growth of any patient-centric healthcare information system but this must be initiated at a national level, which poses a significant challenge," says Mr. John. "EMR solutions tend to significantly change the care delivery process, and this brings added challenges in the form of implementation and change management issues that implementers, providers, governments and users will need to tackle."

However, the industry is expected to overcome these challenges as both primary and hospital care providers are fully aware of the benefits of EMR, which is clearly one of the most anticipated HIT solutions set to be extensively implemented across Europe. Despite the presence of restraining factors, there are many compelling drivers boosting the growth of the EMR markets at an annual rate exceeding 15.0 percent. The market holds an equally promising future for EMR vendors operating in the primary and hospital care sectors.

European Electronic Medical Records Markets is part of the Healthcare and Life Sciences IT Growth partnership Services program, which also includes research in the following markets: Healthcare IT Platforms, Patient Administration Systems in Europe, Clinical Decision Support Systems Markets in Europe, European Patient E-Booking and Healthcare Smart Cards Systems in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...